| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24.4K | Jan 2, 2024 | Direct | ||
| Perspective Therapeutics, Inc. | Director | Stock option (right to buy) | 23K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| CUE | Cue Biopharma, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| CATX | Perspective Therapeutics, Inc. | Dec 12, 2023 | 1 | $0 | 4 | Dec 14, 2023 | Director |
| CATX | Perspective Therapeutics, Inc. | Feb 21, 2023 | 2 | $0 | 4 | Feb 23, 2023 | Director |
| CATX | Isoray, Inc. | Feb 3, 2023 | 0 | $0 | 3 | Feb 13, 2023 | Director |
| CUE | Cue Biopharma, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| CUE | Cue Biopharma, Inc. | May 27, 2022 | 1 | $105K | 4 | May 31, 2022 | Director |
| CUE | Cue Biopharma, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |